Market Trends Stories
Should we be locking in Kimco or Regency Centers
![]() | 3 days ago at Macroaxis By Vlad Skutelnik |
By examining both technical and fundamental indicators for Regency Centers and Kimco, you can see how market fluctuations impact their stock prices. This comparison helps determine if combining these stocks could reduce overall portfolio risk. Additionally, pair trading strategies—such as going long on Kimco while shorting Regency—may offer potential opportunities. Continue Reading...
- REG Regency Centers
- Latest Regency Centers Corp Q4 2025 Earnings Call Highlights Record Rent Spreads and Robust ...
- REG 75.22 -0.26
- Low 74.02
- High 76.35
- Volume 2.2 M
- Alpha 0.13
- Beta 0.17
- Return On Equity 0.0602
- Return On Asset 0.0306
- Profit Margin 0.26 %
- Operating Margin 0.39 %
- Current Valuation 19.13 B
- Shares Outstanding 182.9 M
- Shares Owned By Insiders 0.70 %
- Shares Owned By Institutions 99.30 %
- Number Of Shares Shorted 5.71 M
- Price To Earning 252.92 X
- Price To Book 2.07 X
- Price To Sales 8.78 X
- Revenue 1.55 B
- Gross Profit 1.13 B
- EBITDA 980.61 M
- Net Income 409.84 M
- Cash And Equivalents 122.01 M
- Cash Per Share 0.71 X
- Total Debt 5.94 B
- Debt To Equity 0.64 %
- Current Ratio 0.95 X
- Book Value Per Share 36.16 X
- Cash Flow From Operations 790.2 M
- Short Ratio 4.54 X
- Earnings Per Share 2.80 X
- Price To Earnings To Growth 2.70 X
- Target Price 79.4
- Number Of Employees 495
- Beta 0.94
- Market Capitalization 13.84 B
- Total Asset 13 B
- Retained Earnings (1.99 B)
- Working Capital (123.63 M)
- Current Asset 175.88 M
- Current Liabilities 193.94 M
- Annual Yield 0.04 %
- Five Year Return 3.97 %
- Net Asset 13 B
- Last Dividend Paid 2.82
- Accumulation Distribution 68190.39
- Daily Balance Of Power (0.11)
- Rate Of Daily Change 1.0
- Day Median Price 75.19
- Day Typical Price 75.2
- Price Action Indicator (0.1)
- Period Momentum Indicator (0.26)
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Raphi Shpitalnik
Sometimes, investors need to look beyond the familiar and consider whether a change makes sense. Microsoft (MSFT) continues to be a powerhouse in the tech sector, boasting a market cap of around $3.5 trillion and solid cash reserves of nearly $95 billion. Its recent quarterly revenue of $73.4 billion and an EPS estimate for next year of approximately $18.60 highlight its strong financial footing.
| over a week ago at Macroaxis By Ellen Johnson | ![]() |
When it comes to Texas Instruments Incorporated, investors are looking at a company with a solid foothold in the semiconductor industry. With a market valuation around $194.55 billion and a consistent quarterly earnings growth of 0.7%, TI continues to attract attention. The company boasts a healthy return on assets of 10.7% and a strong cash flow from operations totaling $6.3 billion, underscoring its financial stability.
| over a week ago at Macroaxis By Raphi Shpitalnik | ![]() |
Kimberly Clark (KMB) trades on the NASDAQ with a market cap of around $33.6 billion and has a solid presence in the household products sector. Its stock price hovers near its 50-day moving average of about $102, with recent momentum slightly negative at -1.09, suggesting some cautiousness among traders. The company's return on assets is a healthy 11.33%, and its return on equity stands at roughly 137%, indicating efficient use of shareholder funds.
| over a week ago at Macroaxis By Rifka Kats | ![]() |
Trading Eni SpA ADR stock this February could be appealing given its steady operating margin of 0.0744 and a potential upside of 2.17, suggesting room for growth amid stable industry conditions. However, investors should watch for its maximum drawdown of 6.47 and the overall volatility indicated by a standard deviation of 1.31, which could impact short-term performance.
Main Points
By examining both technical and fundamental indicators for Eni SpA and Kinder, you can see how market fluctuations impact their stock prices. This comparison helps determine if combining these stocks could reduce overall portfolio risk through diversification.| over a week ago at Macroaxis By Nico Santiago | ![]() |
By comparing key indicators of Corvus Pharmaceuticals and Olema, you can see how market swings impact their stock prices and whether combining them could help reduce overall risk. Pair trading strategies—like going long on Olema while shorting Corvus—might also be worth exploring. For more details, check out our pair correlation tool.
| over a week ago at Macroaxis By Rifka Kats | ![]() |
By examining the core fundamentals of Texas Capital Bancshares and ServisFirst, you can see how market swings impact their stock prices. This comparison helps determine if combining these two could reduce overall market risk in your portfolio. Additionally, pair trading strategies—such as going long on ServisFirst while shorting Texas Capital—might offer a way to capitalize on their relative movements.
| over two weeks ago at Macroaxis By Vlad Skutelnik | ![]() |
Recent trading activity suggests that retail investors are showing increased interest in AZZ Incorporated (NYSE:AZZ), a key player in the industrials sector, particularly within specialty business services. Despite the company reporting a loss of $6.06 per share this year, its solid revenue of $1.6 billion and a PE ratio of approximately 11.47 indicate underlying value. Meanwhile, Worthington Industries continues to attract attention, but the shifting investor focus toward AZZ hints at a potential reassessment of its growth prospects and valuation metrics.
| over three weeks ago at Macroaxis By Aina Ster | ![]() |
Investing is often about spotting potential where others see uncertainty. Society Pass, a player in the Communication Services and Software sectors, has caught the eye with its recent financial moves and growth prospects. Despite facing a challenging period with an EBITDA of -9.8 million and an earnings per share estimate for the current year at -1.39, the company has demonstrated some positive cash flow shifts, with cash increasing from 3.7 million to 7.7 million over the period.
| over a month ago at Macroaxis By Aina Ster | ![]() |
By comparing key indicators between Kestra Medical Technologies and Azenta, you can see how market fluctuations impact each company's stock. This analysis helps determine if combining them could reduce overall market risk in your portfolio. You might also consider pair trading—going long on Azenta while shorting Kestra Medical—to capitalize on their relative movements.
| over a month ago at Macroaxis By Gabriel Shpitalnik | ![]() |






